Therapeutic Solutions International Inc (TSOI)
0.0007
0.00 (0.00%)
USD |
OTCM |
Apr 18, 16:00
Therapeutic Solutions International Research and Development Expense (Quarterly): 0.1505M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.1505M |
| September 30, 2023 | 0.1489M |
| June 30, 2023 | 0.2085M |
| March 31, 2023 | 0.0527M |
| December 31, 2022 | 0.275M |
| September 30, 2022 | 0.2751M |
| June 30, 2022 | 0.5979M |
| March 31, 2022 | 0.3042M |
| December 31, 2021 | 0.6112M |
| September 30, 2021 | 0.0318M |
| June 30, 2021 | 0.1321M |
| March 31, 2021 | 0.0197M |
| December 31, 2020 | 0.0983M |
| September 30, 2020 | 0.1339M |
| June 30, 2020 | 0.3298M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.0034M |
| September 30, 2019 | 0.0248M |
| Date | Value |
|---|---|
| June 30, 2019 | 0.0062M |
| March 31, 2019 | |
| December 31, 2018 | 0.0012M |
| September 30, 2018 | 0.0339M |
| June 30, 2018 | 0.0343M |
| March 31, 2018 | |
| December 31, 2017 | 0.001M |
| September 30, 2017 | 0.002M |
| June 30, 2017 | 0.0011M |
| March 31, 2017 | 0.0209M |
| December 31, 2016 | 0.005M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.006M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
-0.0034M
Minimum
Dec 2019
0.6112M
Maximum
Dec 2021
0.1788M
Average
0.1339M
Median
Sep 2020
Research and Development Expense (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.004M |
| Palatin Technologies Inc | 5.554M |
| iBio Inc | 1.535M |
| Theriva Biologics Inc | 4.196M |
| Ampio Pharmaceuticals Inc | 1.242M |